Novavax just isn’t in a very good monetary place to refund cash to prospects because it has undergone a cost-cutting restructuring amid declining gross sales of the Covid-19 vaccine, its solely revenue-generating product. However arbitration is unsure, so fairly than roll the cube and threat an enormous payout if dispute decision fails, the corporate has agreed to pay Gavi, the […]
